To Explore the Relationship between Clinical Serum Markers and Intracoronary in-stent Restenosis

王超权,徐耕,程刚,王翔,任品芳
DOI: https://doi.org/10.3969/j.issn.1009-816X.2009.02.002
2009-01-01
Abstract:Objective To explore the relationship between serum markers and coronary in-stent restenosis after drug-eluting stent implantation. Methods The study enrolled 214 patients who underwent drug-eluting stent implantation and accepted coronary angiography for recurrent chest pain or routine follow-up.The vascular's diameter stenosis ≥50% was used as a definition of restenosis.Patient's clinical data and risk factors for CHD were collected,and the clinical serum markers were detected.Results Among the 214 patients(278 lesions), restenosis occurred in 90 patients(110 lesions) and the restenosis rate was 42.1%.Compared to non-restenosis group,serum markers such as lipoprotein a,conjugated bilirubin,glutamic pyruvictransaminase,aspartate aminotransferase,cholinesterase and fibrinogen in restenosis group had no significant difference;indexes such as serum LDL/HDL,total bile acid,uric acid,alkaline phosphatase and glutaminoacytransferase levels were higher and serum total bilirubin level was lower in restenosis group than those in non-restenosis group(P<0.05).As a result of multivariate regression analysis,diabetes(OR=1.038),high serum level of LDL/HDL(OR=1.542),high total bile acid(OR=1.197),high urine acid(OR=1.113)and long lesion(OR=1.331) were risk factors contributed to restenosis(P<0.05),while high serum total bilirubin level(OR=0.891)was a protecting factor to restenosis(P<0.05).Conclusions Some clinical serum markers such as total bilirubin,total bile acid,urine acid,and LDL/HDL level are closely correlated with in-stent restenosis after drug-eluting stent implantation in coronary artery.
What problem does this paper attempt to address?